Skip to search formSkip to main contentSkip to account menu

Thrombotic thrombocytopenic purpura, acquired

Known as: IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA, Moschowitz syndrome 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Thrombotic thrombocytopenic purpura (TTP) is an acute thrombotic microangiopathy with a high morbidity and mortality if untreated… 
Highly Cited
2010
Highly Cited
2010
Background:  Early initiation of plasma exchange (PE) allows more than 80% of patients with idiopathic thrombotic… 
Highly Cited
2010
Highly Cited
2010
Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin 
2010
2010
Rituximab may be used to treat patients with thrombotic thrombocytopenic purpura (TTP) refractory to plasma exchange or recurrent… 
Highly Cited
2009
Highly Cited
2009
Therapeutic plasma exchange (PE) is the accepted therapy for thrombotic thrombocytopenic purpura (TTP). Because not all patients… 
2009
2009
Abstract 2412 Poster Board II-387 Acquired idiopathic thrombotic thrombocytopenic purpura (TTP) is a rare form of thrombotic… 
Highly Cited
2007
Highly Cited
2007
We hypothesized that ciclosporin (CSA) as adjunct to plasma exchange (PE) improves the efficacy of PE in idiopathic thrombotic… 
Highly Cited
2004
Highly Cited
2004
Abstract: The significance of ADAMTS13 deficiency in adult thrombotic microangiopathy (TMA) remains controversial. In an attempt… 
Highly Cited
2003
Highly Cited
2003
ADAMTS13 consists of a reprolysin-type metalloprotease domain followed by a disintegrin domain, a thrombospondin type 1 motif…